Scaffolds, Stem Cells, and Tissues. Oh, My!
A primer for how the FDA regulates stem cells
A primer for how the FDA regulates stem cells
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
Concerns about skin flap viability have long kept many surgeons from combining these procedures. A new case series takes a closer look at whether that caution is still warranted.